Simple, accurate, precise, reproducible, requiring no prior separation, and economical procedures for simultaneous estimation of benazepril hydrochloride (BEN) and Hydrochlorothiazide (HCT) in tablet dosage form have been developed. Simultaneous equation method employs for estimation of both drugs in methanol at 240?nm and 270?nm as two analytical wavelengths. BEN and HCT at their respective (240?nm and 270?nm) show linearity in a concentration range of 2–12?μg/mL and 4–14?μg/mL. Recovery studies for BEN are 100.0–100.6% and 99.8–100.0% for HCT in the case of simultaneous equation method confirming the accuracy of the proposed method. The proposed method is recommended for routine analysis since it is rapid, simple, accurate and also sensitive and specific. 1. Introduction Benazepril hydrochloride (BEN) is chemically 3-[[1-(ethoxycarbonyl)-3-phenyl-(1S)-propyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid monohydrochloride (Figure 1(a)). The empirical formula of BEN is C24H28N2O5·HCl with a molecular weight of 460.96?g/mole [1]. It is an angiotensin converting enzyme. It is used as antihypertensive agent. Figure 1: (a) Structure of hydrochlorothiazide. (b) Structure of benazepril hydrochloride. Hydrochlorothiazide (HCT) is chemically 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide (Figure 1(b)). The empirical formula is C7H8ClN3O4S2 with a molecular weight 297.73?g/mole [2]. It is a diuretic agent. BEN and HCT are official in the british Pharmacopeia and the Indian Pharmacopeia. Many methods have been reported in the literature for both determination of BEN, individually and with other drugs in combination [3–17]. However, there is no UV spectrophotometric method reported for the simultaneous estimation of BEN and HCT in pharmaceutical preparations in the literature survey. The objective of the present work is to develop and validate new analytical methods for simultaneous determination of BEN and HCT in tablet dosage form. 2. Experimental 2.1. Materials and Methods A double-beam Shimadzu UV-visible spectrophotometer 1700 (Pharma spec), with wavelength accuracy of ±0.5?nm and a pair of 1?cm matched quartz cells, was used to measure absorbance of the resulting solution. All weighing was done on an electronic balance (Shimadzu BL-220H). All statistical calculations were carried out using Microsoft Excel 2007 analytical tool. Analytically pure BEN and HCT were procured as gift sample from Dishman Pharmaceuticals Ltd. and Cadila Pharmaceutical Pvt. Ltd. (Ahmedabad, India). Methanol (E. Merck, Mumbai, India)
References
[1]
British Pharmacopoeia 2011, vol. 2,The Department of Health, Social Services and Public Safety, pp. 225–226, 2011.
[2]
Indian Pharmacopoeia 2007, vol. 2, Government of India, The Indian Pharmacopoeia Commission, Ghaziabad, Ministry of Health & Family Welfare, pp. 576–578, 2007.
[3]
P. Y. Pawar, R. S. Joshi, V. Sandhan, S. Wagh, and K. Jangale, “Simultaneous spectrophotometric estimation of amlodipine besylate and benazepril HCl in pure and pharmaceutical dosage form,” Der Pharmacia Lettre, vol. 3, no. 3, pp. 397–403, 2011.
[4]
K. R. Naidu, U. N. Kale, and M. S. Shingare, “Stability indicating RP-HPLC method for simultaneous determination of amlodipine and benazepril hydrochloride from their combination drug product,” Journal of Pharmaceutical and Biomedical Analysis, vol. 39, no. 1-2, pp. 147–155, 2005.
[5]
M. Sarat, P. M. krishna, and C. Rambabu, “Development and validation of RP-HPLC method for simultaneous estimaton of amlodipine besyate and benazepril Hcl in tablet,” International Journal of Current Pharmaceutical Research, vol. 4, no. 3, pp. 80–84, 2012.
[6]
K. Safeer, B. Anbarasi, and N. S. Kumar, “Analytical method development and validation of amlodipine and hydrochlorothiazide in combined dosage form by RP-HPLC,” International Journal of ChemTech Research, vol. 2, no. 1, pp. 21–25, 2010.
[7]
G. Patel, S. Patel, D. Prajapiti, and R. Mehta, “RP-HPLC method for simultaneous estimation of amlodipine besylate and hydrochlorothiazide in combined dosage forms,” Stamford Journal of Pharmaceutical Sciences, vol. 3, no. 1, pp. 49–35, 2010.
[8]
L. A. Rao and R. V. Bhaskara, “Simultaneous estimation of valsarten and hydrochlorthiazide in tablets by RP-HPLC method,” Intnational Journal Pharmaceutical & Industrial Reserch, vol. 1, no. 3, pp. 170–174, 2011.
[9]
M. Kharoaf, N. Malkieh, M. Abualhasan, R. Shubitah, N. Jaradat, and A. N. Zaid, “Tablet formulation and development of a validated stability indicating HPLC method for quantification of valsarten and hydrochlorthiazide combination,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 4, pp. 683–687, 2012.
[10]
A. R. Chabukswar, S. C. Jagdale, B. S. Kuchekar et al., “Development and validation of a RP-HPLC method for simultaneous estimation of hydrochlorothiazide and irbesartan,” Der Pharma Chemica, vol. 2, no. 4, pp. 148–156, 2010.
[11]
R. Rosangluaia, P. Shanmugasundaram, and M. Velraj, “Validated HPTLC method for simultaneous estimation of irbesartan and hydrochlorthiazide in a tablet dosage form,” Der Pharma Chemica, vol. 3, no. 5, pp. 310–317, 2011.
[12]
S. Brijesh, D. K. Patel, and S. K. Ghosh, “Development of reverse-phase HPLC method for simultaneous analysis of metoprolol succinate and hydrochlorothiazide in a tablet formulation,” Tropical Journal of Pharmaceutical Research, vol. 8, no. 6, pp. 539–543, 2009.
[13]
S. T. Kumbhar, G. K. Chougule, V. S. Tegeli, G. B. Gajeli, V. S. Thorat, and U. S. Shivsharan, “A validated HPTLC method for simultaneous quantification of nebivolol and hydrochlorothiazide in bulk and tablet formulation,” International Journal of Pharmaceutical Sciences and Drug Research, vol. 3, no. 1, pp. 62–66, 2011.
[14]
Y. Gupta, A. Shrivastava, D. Duggal, A. Patel, and S. Agrawal, “A new RP-HPLC method for simultaneous estimation of nebivolol hydrochloride and hydrochlorthiazide in dosage forms,” Journal Young Pharmacist, vol. 1, no. 3, pp. 264–269, 2009.
[15]
S. A. Hapse, V. S. Wagh, P. T. Kadaskar, M. D. Dokhe, and A. S. Shirsath, “Spectrophotometric estimation and validation of hydrochlorothiazide in tablet dosage forms by using different solvents,” Der Pharma Chemica, vol. 4, no. 1, pp. 10–114, 2012.
[16]
A. El-Gindy, A. Ashour, L. Abdel-Fattah, and M. M. Shabana, “Application of LC and HPTLC-densitometry for the simultaneous determination of benazepril hydrochloride and hydrochlorothiazide,” Journal of Pharmaceutical and Biomedical Analysis, vol. 25, no. 2, pp. 171–179, 2001.
[17]
I. E. Panderi and M. Parissi-Poulou, “Simultaneous determination of benazepril hydrochloride and hydrochlorothiazide by micro-bore liquid chromatography,” Journal of Pharmaceutical and Biomedical Analysis, vol. 21, no. 5, pp. 1017–1024, 1999.
[18]
“Validation of analytical procedures: methodology,” in ICH Harmonized Tripartite Guidelines, 2005.